{content}

Study list

FOLLOW-COVID

United Kingdom
|
2020
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • Primary care
  • SARS-CoV-2
  • Post COVID-19 condition
  • Blood sample
  • Stool sample

FemiAjao

United Kingdom
|
2020
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post COVID-19 condition

COPP2-study

The Netherlands
|
2020
  • General population
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Outpatient clinic
  • Emergency department
  • SARS-CoV-2
  • Post COVID-19 condition

Hedberg

Sweden
|
2020-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Outpatient clinic
  • Primary care
  • SARS-CoV-2
  • Post COVID-19 condition

Ferro

Italy
|
2020-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Hospital
  • Intensive care unit
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Immunomodulator
  • Steroids
  • Baricitinib
  • Dexamethasone
  • Methylprednisolone

Kautsch

Poland
|
2020-2023
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Mengato

Italy
|
2020-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Hospital
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Wildi

Argentina Australia Brazil Germany Hong Kong Italy Japan South Africa Spain United States of America Ireland
|
2020
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Fragile population
  • Hospital
  • Intensive care unit
  • SARS-CoV-2
  • Post COVID-19 condition

Long-Neuro-COVID-19

Germany
|
2020-2024
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

Geismar

United Kingdom
|
2020-2022
  • General population
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Community
  • Household
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Respiratory syncytial virus infection
  • Influenza
  • COVID-19

SARS-CoV-2-Follow-Up

Germany
|
2020
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Blood sample
  • Stool sample

Vonkeman

The Netherlands
|
2020-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Post COVID-19 condition

Zurich Coronavirus Cohort

Switzerland
|
2020
  • Adults (18-64 years)
  • General population
  • Community
  • Non-hospital health centre
  • SARS-CoV-2
  • Post COVID-19 condition

PHOSP-COVID

United Kingdom
|
2020
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Intensive care unit
  • SARS-CoV-2
  • Post COVID-19 condition

HeijenbrokKal

The Netherlands
|
2020
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post COVID-19 condition

Pereta

Spain
|
2020-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • Community
  • SARS-CoV-2
  • Acute COVID-19
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

CO-Qo-ICU

France
|
2020-2025
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Intensive care unit
  • SARS-CoV-2
  • Post COVID-19 condition

Co-SURVIVORS

France
|
2020
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition

CAPACoV19

France
|
2020-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Post COVID-19 condition

Urban

Austria
|
2020-2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Hospital
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • HIV
  • Hepatitis B
  • Hepatitis C
  • Sexually transmitted infection
  • Syphilis
  • Chlamydia
  • Gonorrhea
  • HIV

PoLoCOV-Study

Poland
|
2020-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Post COVID-19 condition

CISCO-19

United Kingdom
|
2020-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Post COVID-19 condition

SECOV

Germany
|
2020-2025
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Post COVID-19 condition
  • Blood sample
  • PBMC
  • Serum

Löffelhardt

Germany
|
2020
  • Adults (18-64 years)
  • General population
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition